About Livzon Pharmaceutical
Livzon Pharmaceutical is a publicly listed company based in Shanghai (China) founded in 1985. Manufacturer drug preparation, bulk medicines, and intermediates. The company has 9,070 employees. Livzon Pharmaceutical has completed 2 acquisitions, including Imexpharm and Livzon Group Fuzhou Fuxing Pharmaceutical. Its chief executive, as recorded, is Desheng Tao. Its website livzon.com.cn draws about 16 thousand monthly visits. Livzon Pharmaceutical offers products and services including Injectable Drugs and Vaccines and Biologics. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity in India is δΈ½η ε»θ―ιε’θ‘δ»½ζιε ¬εΈ (U99999MH1977PLC010754).
Company details
Livzon Pharmaceutical was established in 1985 and is based in Shanghai, China. Operations focus on the pharmaceutical sector, where drug preparations, bulk medicines, intermediates, diagnostic reagents, and equipment are produced. A portfolio of products is maintained for gastrointestinal, cardio-cerebral-vascular, antibiotic, gonadotropic hormone, and blood and hemopoietic system applications. The company serves these areas through its manufacturing activities.
- Headquarters Shanghai, China
- Employees 9,070
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website livzon.com.cn
- Legal Name Livzon Pharmaceutical Group, Inc. Class A
- Annual Revenue$1.7 B (USD)1.67as on Dec 31, 2025
- Net Profit$288.53 M (USD)-1.84as on Dec 31, 2025
- EBITDA$454.22 M (USD)0.03as on Dec 31, 2025
- Employee Count9,070
- Investments & AcquisitionsImexpharm
& 1 more
Associated legal entities of Livzon Pharmaceutical
Livzon Pharmaceutical operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of Livzon Pharmaceutical
Livzon Pharmaceutical offers a comprehensive portfolio of products and services, including Injectable Drugs and Vaccines and Biologics.
Various injectable medications, such as Aripiprazole Microspheres, are produced for therapeutic uses in healthcare settings
Vaccines and biologic products, including recombinant proteins, are developed and supplied for disease prevention and treatment
People of Livzon Pharmaceutical
1 people are tracked at Livzon Pharmaceutical (1 in leadership); the tracked headcount is 9,070.
| Name | Role | Group |
|---|---|---|
Desheng Tao | CEO & President | Leadership |
Complete people profiles for Livzon Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Livzon Pharmaceutical
Livzon Pharmaceutical is a publicly listed company on the SZSE with ticker symbol 000513 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Sep 1993
- Listed onSZSE: 000513
- Listed entityLivzon Pharmaceutical Group, Inc. Class A
- Exchange sectorHealth technology
- ISINCNE0000002Y8
- Share price28.01 CNY (-4.83% on the day) · 2026-10-14
- Market capitalisation23,012,787,206.02 CNY
- Price to earnings14.8
- EPS (diluted, trailing year)1.89 CNY
- Dividend yield4.86%
- Volume (last session)13,479,420
Financials of Livzon Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 11.91B CNY | 2.02B CNY | 3.18B CNY |
| 2024 | 11.71B CNY | 2.06B CNY | 3.18B CNY |
| 2023 | 12.32B CNY | 1.95B CNY | 2.79B CNY |
| 2022 | 12.52B CNY | 1.91B CNY | 2.60B CNY |
| 2021 | 11.96B CNY | 1.78B CNY | 2.39B CNY |
Balance sheet, profit and loss, cash flow and ratios of , are on its company page.
Detailed financial statements for Livzon Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Livzon Pharmaceutical
Livzon Pharmaceutical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Imexpharm and Livzon Group Fuzhou Fuxing Pharmaceutical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Diversified generic drugs are manufactured by Imexpharm in Vietnam. | imexpharm.com | Cao Lanh, Vietnam | 1983 | May 2025 | $219M | |
API and intermediates for antibiotics and food additives are manufactured. | fxpharm.com | Fuzhou, China | 1979 | Jun 2004 | β’β’β’β’ |
Complete acquisition details for Livzon Pharmaceutical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Livzon Pharmaceutical
4 dated milestones of Livzon Pharmaceutical across 40 years, from founding to its latest funding, stage changes and deals.
- Founded Livzon Pharmaceutical is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Livzon Group Fuzhou Fuxing Pharmaceutical.
- Acquisition Acquires Imexpharm.
Web traffic of Livzon Pharmaceutical
The website of Livzon Pharmaceutical (livzon.com.cn) receives about 15.5K visits a month and ranks #1,950,414 among all websites worldwide, #2,657 in Biotechnology and Pharmaceuticals.
- Monthly visits15.5K
▲ 69.8% vs previous month
- Unique visitors4K
per month
- Global rank#1,950,414
among all websites
- Category rank#2,657
Health · Biotechnology and Pharmaceuticals
- Bounce rate32%
- Pages per visit3.1
- Average visit3 sec
- DevicesDesktop 13% Β· Mobile 87%
Websites whose visitors overlap most with Livzon Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hansoh.cn | 100% | #3,059,724 | View details | ||
| 3sbio.com | 100% | 17.5K | View details | ||
| hisunpharm.com | 100% | 100.8K | View details | ||
| novartis.com | 100% | 948.8K | #58,822 | View details | |
| yangzijiang.com | 100% | #559,311 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 14 similar websites and full traffic analytics for Livzon Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Livzon Pharmaceutical
Complete news archive for Livzon Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Livzon Pharmaceutical
Livzon Pharmaceutical was founded in 1985.
Livzon Pharmaceutical is headquartered in Shanghai, China.
Desheng Tao is the CEO of Livzon Pharmaceutical, as recorded in our data.
Livzon Pharmaceutical has 9,070 employees.
Annual revenue of Livzon Pharmaceutical is $1.7B as on Dec 31, 2025.
Livzon Pharmaceutical was established in 1985 and is based in Shanghai, China. Operations focus on the pharmaceutical sector, where drug preparations, bulk medicines, intermediates, diagnostic reagents, and equipment are produced. A portfolio of products is maintained for gastrointestinal, cardio-cerebral-vascular, antibiotic, gonadotropic hormone, and blood and hemopoietic system applications. The company serves these areas through its manufacturing activities.
Livzon Pharmaceutical offers Injectable Drugs and Vaccines and Biologics.
Yes, Livzon Pharmaceutical is publicly traded on SZSE under the ticker symbol 000513.
Livzon Pharmaceutical has made 2 acquisitions, including Imexpharm, and Livzon Group Fuzhou Fuxing Pharmaceutical.
Livzon Pharmaceutical operates through ,.